GOSH Consultant, Dr Emma Clement, joins the North Thames Genomic Medicine Service as Deputy Medical Director

12 Jan 2026, 10:56 a.m.

A woman with short brown hair is smiling.

We are delighted to share that Dr Emma Clement has joined the North Thames Genomic Medicine Service (NT GMS) Deputy Medical Director. She joins the NT GMS senior team and will work alongside Medical Director, Dr Angela George, and COO, Anthony Sullivan, to deliver the genomics ambitions of the 10-Year Plan.

Dr Sophia Varadkar, GOSH Acting Chief Medical Officer and Acting Senior Responsible Officer for the NT GMS said: “We are absolutely delighted to welcome Dr Emma Clement as Deputy Medical Director for the North Thames Genomic Medicine Service, she brings with her fantastic experience of integrating genomics into routine clinical care which will be vital as the service continues to expand.”

Dr Clement has been a Consultant in Clinical Genetics and Genomic Medicine at GOSH since 2017 and played a significant role in the delivery of the 100,000 genomes project at the hospital. She has a specialist interest in paediatric rare disease, particularly in the genetics of hearing loss and dual sensory conditions.

Dr Angela George, NT GMS Medical Director said: "It is fantastic to have Dr Emma Clement joining our NT GMS team and I am excited to be working with her as we continue to build our service. Emma’s track record in embedding genomics into routine clinical care, alongside her leadership in education and paediatric rare disease, will be invaluable as we deliver our ambitions across North Thames and improve outcomes for patients."

Dr Clement brings a wealth of experience to the role, having worked closely with other clinical teams across GOSH to embed genomic sequencing into routine care.

Dr Emma Clement said: "I am really happy to be stepping into the role of Deputy Medical Director for the North Thames GMS. I'm looking forward to working collaboratively across our region to help embed genomics into routine patient care."

From staff idea to global innovation: Taking the next step towards improving patient safety

A simple idea developed by a GOSH clinician has secured a commercial partner.

Four research projects receive funding to improve understanding and treatment of childhood cancer

Researchers at Great Ormond Street Hospital (GOSH) and UCL Great Ormond Street Institute of Child Health (UCL GOS ICH) have received funding from The Little Princess Trust for four childhood cancer research projects.

New study brings hope for children with rare life-threatening kidney disease

New research funded by Great Ormond Street Hospital Charity (GOSH Charity), LifeArc and Kidney Research UK has taken an important step towards developing a new treatment for serious genetic kidney diseases affecting children.